Actinic Keratosis
Chemical Peels in Skin Cancer: A Review
J Clin Aesthet Dermatol. 2020;13(2):53–57 by Polytimi Sidiropoulou, MD; Stamatis Gregoriou, MD, PhD; Dimitris Rigopoulos, MD, PhD; and Georgios Kontochristopoulos, MD, PhD Drs. Sidiropoulou, Gregoriou and Rigopoulos are with the 1st Department of Dermatology-Venereology of the National and Kapodistrian University of Athens at Andreas Syggros Hospital for Cutaneous & Venereal Diseases in Athens, Greece. Dr. […]
Regarding recently published article on Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for Treatment of Actinic Keratosis
Dear Editor: In their article, “Safety and efficacy of aminolevulinic acid 10% topical gel versus aminolevulinic acid 20% topical solution followed by blue-light photodynamic therapy for the treatment of actinic keratosis on the face and scalp: A randomized, double-blind study,” Nestor et al assessed the response of actinic keratosis (AK) lesions in two 25-cm2 areas […]
Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study
J Clin Aesthet Dermatol. 2019;12(3):32–38 by Mark S. Nestor, MD, PhD; Brian Berman, MD, PhD; Jigesh Patel, BS; and Alec Lawson Drs. Nestor and Berman and Messrs. Patel and Lawson are with the Center for Clinical and Cosmetic Research in Aventura, Florida. Drs. Nestor and Berman are also with the Department of Dermatology and Cutaneous […]
Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial
by Daniel M. Siegel, MD; Stephen Tyring, MD, PhD; Walter K. Nahm, MD, PhD; Marie Louise Østerdal, MSc; Astrid H. Petersen, PhD; and Brian Berman, MD, PhD Dr. Siegel is with Long Island Skin Cancer and Dermatologic Surgery in New York, New York. Dr. Tyring is with the Center for Clinical Studies in Houston, Texas. […]
Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial
by Brian Berman, MD, PhD; Stephen Tyring, MD, PhD; Walter K. Nahm, MD, PhD; Marie Louise Østerdal, MSc; Astrid H. Petersen, PhD; and Daniel M. Siegel, MD Dr. Berman is Co-Director at Center for Clinical and Cosmetic Research in Aventura, Florida. Dr. Tyring is Medical Director at the Center for Clinical Studies at University of […]
Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015%
by Orit Markowitz, MD; Katie Wang, DO; Amanda Levine, MD; Michelle Schwartz, BA; Sumeet Minhas, BA; Eleanor Feldman, BA; and Daniel M. Siegel, MD Drs. Markowitz, Wang, Levine; Ms. Minhas; and Ms. Schwartz and Ms. Feldman are associated with the Department of Dermatology, SUNY Downstate Medical Center, New York, New York; the Department of Dermatology, […]
A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest
by Douglas C. Wu, MD, PhD; Isabella Guiha, BSc; and Mitchel P. Goldman, MD Drs. Wu and Goldman and Ms. Guiha are with Cosmetic Laser Dermatology, San Diego, California. J Clin Aesthet Dermatol. 2017;10(8):31–36 Funding: This study was sponsored and funded by LEO Pharma. Disclosures: The authors have no conflicts of interest relevant to the […]
